AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.
about
Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementThe collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparityMatrix stiffening promotes a tumor vasculature phenotype.Mechanotransduction in cancer.Endo180 at the cutting edge of bone cancer treatment and beyond.Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.Hypoxia driven glycation: Mechanisms and therapeutic opportunities.The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases.Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression.Opportunities for organoids as new models of aging.Charting the unexplored extracellular matrix in cancer.Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180
P2860
Q26781156-8849696B-DF62-4674-AAAD-A5FC9C7D7955Q26796487-CD33B90E-0478-4D46-B996-5EF4FD4E9019Q27316928-E7E08D7B-19A1-46DC-B580-C79E2CAAD99DQ28087670-B54F0E55-55E7-4677-AD7B-961369852E16Q37598974-4DA3360D-3CFF-485C-94E9-68CB7B72F448Q37716062-425841E6-69D9-4F72-BF9D-6121C7EFA63EQ38635803-270BBFC9-C3FA-4ED9-98F8-F20F93DA0BC3Q38698770-39F90217-BBA7-4420-A3A5-FBE53B71E4E4Q39331191-F7410174-DC13-4C18-A1A6-08560C848FEAQ41280225-A5B16F8E-C0E4-4E12-B5EC-CDC7980B1099Q42375555-949948F9-F644-443A-92C1-5120E49229A5Q45073825-01FD26E7-FCF0-4E7C-8DC4-B635B88CACFEQ47562383-19CFF230-5FE5-4D4E-BC32-AE26807B5F22Q52315803-01225D68-5139-42DD-AEAB-E57C0E877D16Q57680380-48818666-365A-4CF5-B957-14BC88926189
P2860
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
AGE-modified basement membrane ...... ease prostate cancer survival.
@en
type
label
AGE-modified basement membrane ...... ease prostate cancer survival.
@en
prefLabel
AGE-modified basement membrane ...... ease prostate cancer survival.
@en
P2093
P2860
P50
P356
P1476
AGE-modified basement membrane ...... rease prostate cancer survival
@en
P2093
Afshan McCarthy
Ai Minamidate
Claudia Breit
Craig Robson
Francesco Mauri
Jonathan Waxman
Julian H Gronau
Luke Gaughan
Matthew P Caley
Yu Zhi Zhang
P2860
P304
P356
10.1002/PATH.4485
P577
2014-12-24T00:00:00Z